Islas-Cortez Marcela, Ríos Camilo, Manzanares Jorge, Díaz-Ruiz Araceli, Pérez-Pastén-Borja Ricardo
Laboratorio de Toxicología Molecular, Departamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 07738, Mexico.
Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Ciudad de México 14269, Mexico.
Antioxidants (Basel). 2024 Jun 8;13(6):705. doi: 10.3390/antiox13060705.
Oxidative stress and apoptosis cell death are critical secondary damage mechanisms that lead to losing neighboring healthy tissue after cerebral ischemia. This study aims to characterize the type of interaction between dapsone (DDS) and cannabidiol (CBD) and its cytoprotective effect in an in vitro model of oxygen and glucose deprivation for 6 h followed by 24 h of reoxygenation (OGD/R), using the SH-SY5Y cell line. For the combined concentrations, an isobolographic study was designed to determine the optimal concentration-response combinations. Cell viability was evaluated by measuring the lactate dehydrogenase (LDH) release and 3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assays. Also, the reactive oxygen species (ROS) and reduced glutathione (GSH) levels were analyzed as oxidative stress markers. Finally, caspase-3 activity was evaluated as a marker cell death by apoptosis. The results showed a decrease in cell viability, an increase in oxidant stress, and the activity of caspase-3 by the effect of OGD/R. Meanwhile, both DDS and CBD demonstrated antioxidant, antiapoptotic, and cytoprotective effects in a concentration-response manner. The isobolographic study indicated that the concentration of 2.5 µM of DDS plus 0.05 µM of CBD presented a synergistic effect so that in treatment, cell death due to OGD/R decreased. The findings indicate that DDS-CBD combined treatment may be a helpful therapy in cerebral ischemia with reperfusion.
氧化应激和凋亡性细胞死亡是导致脑缺血后邻近健康组织丧失的关键继发性损伤机制。本研究旨在利用SH-SY5Y细胞系,在氧糖剥夺6小时后再复氧24小时(OGD/R)的体外模型中,表征氨苯砜(DDS)和大麻二酚(CBD)之间的相互作用类型及其细胞保护作用。对于联合浓度,设计了等效线图研究以确定最佳浓度-反应组合。通过测量乳酸脱氢酶(LDH)释放和3-[4,5-二甲基-2-噻唑基]-2,5-二苯基-2H-四氮唑溴盐(MTT)试验来评估细胞活力。此外,分析活性氧(ROS)和还原型谷胱甘肽(GSH)水平作为氧化应激标志物。最后,评估半胱天冬酶-3活性作为细胞凋亡导致的细胞死亡标志物。结果显示,OGD/R的作用导致细胞活力下降、氧化应激增加和半胱天冬酶-3活性增加。同时,DDS和CBD均以浓度-反应方式表现出抗氧化、抗凋亡和细胞保护作用。等效线图研究表明,2.5 µM的DDS加0.05 µM的CBD浓度呈现协同作用,因此在治疗中,OGD/R导致的细胞死亡减少。研究结果表明,DDS-CBD联合治疗可能是脑缺血再灌注的一种有效治疗方法。